Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer

NCT00082862 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: recombinant interferon alfa
DRUG: cisplatin
DRUG: gemcitabine hydrochloride
PROCEDURE: hyperthermia treatment

Sponsor

The University of Texas Health Science Center, Houston